A VISIONaerie® approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye
News HighlightsAerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug ... Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From... Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval ...
Oct 21, 4:00 PM ET
52 - WEEK LOW/HIGH